1Tatemoto K,Carlquist M, Mutt V, Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptlde [J]. Nature, 1982,296 ( 5858 ) :659-660.
2Pheng LH, Regoli D. Receptors for NPY in peripheral tissues bioassays [ J]. Life Sei,2000,67:847.
3Lundell I, Boswell T, Larhammar D. Chicken neuropeptide yfamily receptor Y4:a receptor with equal affinity for pancreatic polypeptide, neuropeptide Y and peptide Y Y[ J]. J Mol Endoerinol,2002,28:225-235.
4Wolak ML, DeJoseph MR, Cator AD, et al. Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry[J]. J Co mp Neurol,2003,464:285-311.
5Onuoha GN, Nicholls DP, Alpar EK, et al. Regulatory peptides in the heart andmajor vessels ofman andmammals [ J ]. Neuropeptides, 1999,33 ( 2 ) : 165- 172.
6Ericsson A,SchallingM, Mclntyre KR, et al. Detection of neuropeptide Y and itsmRNA inmegakaryocytes:Enhanced levels in certain autoimmune mice[ J]. Proc Nad Acad Sci USA,1987,84(16) :5585-5589.
7MorrisMJ,CoxHs,Lambert GW,et al. Region specific ncuropeptide Y overflows at rest and during synpathetic activation in humans[ J]. Hypertension, 1997, 29 (1) : 137-143.
8Michel MC, Beek-Sickinger A, Cox H, et al. International union of pharmacology recommendations for the nomenclature of neuropeptide Y,peptide YY, and pancreatic polypeptide receptors [ J ]. Pharmaeol Rev, 1998,50 ( 1 ) : 143-150.
9Goldberg Y, Taimor G, Piper HM, et al. Intracellular signaling leads to the hypertrophic effects of neuropeptide Y [ J ]. Am J Physiol, 1998,275 (5 Pt 1 ): C1207-1215.
10Miller DW, Tessel RE. Age-dependent hyperresponslveness of spontaneously hypertensive rats to the pressor effects of intravenous neuropeptide Y (NPY) : role of mode of peptide administration andplasma NPY-like immunoreactivity [ J ]. J Cardiovase Pharmacol, 1991, 18 : 647-656.
